Eli Lilly, Novo Nordisk win antitrust suit against compound pharmacy

A federal judge sided with Eli Lilly and Novo Nordisk, dismissing an antitrust lawsuit brought by a compounding pharmacy. The lawsuit alleged the pharma giants were stifling competition in the GLP-1 market. This win protects the big pharma hold on these popular drugs.